All you need to get started with ETF selection and analysis. Create your account now →

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

ETF IssuersVanEckTRUH
TRUH

VanEck Healthcare TruSector ETF

Active ETFEquity
Not rated

The TRUH Exchange Traded Fund (ETF) is provided by VanEck. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

$30.28
-$0.28 (-0.92%) today
1:30 PM 08/26/26 Closed
1D price range
$30.28$30.33
52W price range
$24.89$30.64
YTD Perf.
+19.11%
YTD Flows
Annualized volatility
Fund AuM
€524K
Share class AuM
€524K
TTM Yield
Tracking Error
Tracking Difference
ISIN
US92189Y7094
TER
0.1%
Inception date
4/1/2026
Issuer
Dividend policy
Compare similar ETFs
API
PerformanceApr 2, 2026 - Aug 25, 2026
0%5%10%15%20%MAYJULMAYJUL
Flows
Join for free to unlock
Data as of 07/31/26
Healthcare
97.78%
Consumer Non-Cyclicals
2.28%
Latest TRUH news

No content available for this fund

FAQ about TRUH

TRUH is a Active ETF. This ETF provides exposure to Other Large and Mid-Cap Health Care Equities.
TRUH carries a total expense ratio (TER) of 0.1%, indicating the annual cost for holding the fund.
TRUH was introduced to the market on April 1, 2026. It trades on United States
VanEck Healthcare TruSector ETF, TRUH, is provided by VanEck. Learn more about VanEck here.
TRUH oversees €524K in assets as of August 25, 2026.
TRUH follows a distributing dividend policy, meaning it pays out income to investors.
As of July 31, 2026, TRUH has significant geographic allocations in USA and Ireland.
As of July 31, 2026, TRUH focuses largely on Healthcare and Consumer Non-Cyclicals.
As of July 31, 2026, TRUH holds 59 positions in its portfolio, with 72.03% of assets concentrated in its top 15 holdings.
As of July 31, 2026, TRUH top three holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
The base currency of TRUH is USD.
Data as of 07/31/26
Eli Lilly & Co.
15.53%
Johnson & Johnson
10.55%
AbbVie, Inc.
7.58%
UnitedHealth Group, Inc.
6.43%
Merck & Co., Inc.
5.50%
Thermo Fisher Scientific, Inc.
3.65%
Amgen, Inc.
3.53%
Abbott Laboratories
3.14%
Gilead Sciences, Inc.
2.77%
Pfizer Inc.
2.44%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight